{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:56:08Z","timestamp":1790841368966,"version":"4.1.0"},"reference-count":239,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Nantong Natural Science Foundation","award":["JC2023042"],"award-info":[{"award-number":["JC2023042"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82607575"],"award-info":[{"award-number":["82607575"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473926"],"award-info":[{"award-number":["82473926"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Synaptic dysfunction and intracellular accumulation of pathological tau are convergent hallmarks of Alzheimer\u2019s disease (AD) and related tauopathies, yet the molecular mechanisms coupling these events to widespread neurodegeneration remain incompletely understood. The Src family kinase Fyn has emerged as a critical signaling hub that integrates upstream pathogenic triggers, such as amyloid-\u03b2 (A\u03b2), with downstream neurotoxic cascades. Here, we review the multifaceted roles of Fyn in orchestrating synaptic failure, highlighting how Fyn recruitment by mislocalized tau promotes N-methyl-D-aspartate receptor hyperactivation and calcium dysregulation. We examine the biophysical basis of Fyn\u2013tau interactions, particularly the role of liquid\u2013liquid phase separation in stabilizing toxic signaling complexes. We also discuss how aberrant Fyn signaling in microglia and astrocytes amplifies neuroinflammation. Finally, we evaluate the potential of Fyn as a therapeutic target, emphasizing the necessity of strategies that selectively uncouple pathological signaling from physiological functions to effectively halt disease progression.<\/jats:p>","DOI":"10.1186\/s40035-026-00590-0","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:15:46Z","timestamp":1790820946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fyn kinase: a key mechanistic regulator and therapeutic target in tauopathy and neurodegenerative diseases"],"prefix":"10.1186","volume":"15","author":[{"given":"Haiwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchao","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"6","key":"590_CR1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, et al. tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 2010;68(6):1067\u201381.","journal-title":"Neuron"},{"issue":"36","key":"590_CR2","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.1523\/JNEUROSCI.2357-10.2010","volume":"30","author":"H Zempel","year":"2010","unstructured":"Zempel H, Thies E, Mandelkow E, Mandelkow EM. A\u03b2 oligomers cause localized Ca2+ elevation, missorting of endogenous tau into dendrites, tau phosphorylation, and destruction of microtubules and spines. J Neurosci. 2010;30(36):11938\u201350.","journal-title":"J Neurosci"},{"issue":"3","key":"590_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell. 2010;142(3):387\u201397.","journal-title":"Cell"},{"issue":"11","key":"590_CR4","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1523\/JNEUROSCI.16-11-03601.1996","volume":"16","author":"MM Black","year":"1996","unstructured":"Black MM, Slaughter T, Moshiach S, Obrocka M, Fischer I. tau is enriched on dynamic microtubules in the distal region of growing axons. J Neurosci. 1996;16(11):3601\u201319.","journal-title":"J Neurosci"},{"issue":"18","key":"590_CR5","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1523\/JNEUROSCI.16-18-05727.1996","volume":"16","author":"JW Mandell","year":"1996","unstructured":"Mandell JW, Banker GA. A spatial gradient of tau protein phosphorylation in nascent axons. J Neurosci. 1996;16(18):5727\u201340.","journal-title":"J Neurosci"},{"key":"590_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.671779","volume":"14","author":"X Yin","year":"2021","unstructured":"Yin X, Zhao C, Qiu Y, Zhou Z, Bao J, Qian W. Dendritic\/post-synaptic tau and early pathology of Alzheimer\u2019s disease. Front Mol Neurosci. 2021;14:671779.","journal-title":"Front Mol Neurosci"},{"issue":"6257","key":"590_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/343461a0","volume":"343","author":"A Caceres","year":"1990","unstructured":"Caceres A, Kosik KS. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature. 1990;343(6257):461\u20133.","journal-title":"Nature"},{"issue":"Pt 4","key":"590_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1242\/jcs.107.4.869","volume":"107","author":"B Esmaeli-Azad","year":"1994","unstructured":"Esmaeli-Azad B, McCarty JH, Feinstein SC. Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. J Cell Sci. 1994;107(Pt 4):869\u201379.","journal-title":"J Cell Sci"},{"issue":"5866","key":"590_CR9","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.1152993","volume":"319","author":"R Dixit","year":"2008","unstructured":"Dixit R, Ross JL, Goldman YE, Holzbaur EL. Differential regulation of dynein and kinesin motor proteins by tau. Science. 2008;319(5866):1086\u20139.","journal-title":"Science"},{"key":"590_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.908881","volume":"14","author":"X Fan","year":"2022","unstructured":"Fan X, Xia L, Zhou Z, Qiu Y, Zhao C, Yin X, et al. tau acts in concert with kinase\/phosphatase underlying synaptic dysfunction. Front Aging Neurosci. 2022;14:908881.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"590_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neuint.2011.12.013","volume":"60","author":"Q Chen","year":"2012","unstructured":"Chen Q, Zhou Z, Zhang L, Wang Y, Zhang YW, Zhong M, et al. Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF. Neurochem Int. 2012;60(3):233\u201342.","journal-title":"Neurochem Int"},{"issue":"2","key":"590_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1073858416633439","volume":"23","author":"P Regan","year":"2017","unstructured":"Regan P, Whitcomb DJ, Cho K. Physiological and pathophysiological implications of synaptic tau. Neuroscientist. 2017;23(2):137\u201351.","journal-title":"Neuroscientist"},{"issue":"11","key":"590_CR13","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/nm.4199","volume":"22","author":"X Zhao","year":"2016","unstructured":"Zhao X, Kotilinek LA, Smith B, Hlynialuk C, Zahs K, Ramsden M, et al. Caspase-2 cleavage of tau reversibly impairs memory. Nat Med. 2016;22(11):1268\u201376.","journal-title":"Nat Med"},{"issue":"5","key":"590_CR14","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.18632\/aging.101239","volume":"9","author":"C Bories","year":"2017","unstructured":"Bories C, Arsenault D, Lemire M, Tremblay C, De Koninck Y, Calon F. Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer\u2019s disease. Aging (Albany NY). 2017;9(5):1386\u2013403.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"590_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/BF00293464","volume":"81","author":"E Masliah","year":"1991","unstructured":"Masliah E, Hansen L, Albright T, Mallory M, Terry RD. Immunoelectron microscopic study of synaptic pathology in Alzheimer\u2019s disease. Acta Neuropathol. 1991;81(4):428\u201333.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"590_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30(4):572\u201380.","journal-title":"Ann Neurol"},{"issue":"10","key":"590_CR17","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol Aging. 2006;27(10):1372\u201384.","journal-title":"Neurobiol Aging"},{"issue":"Pt 21","key":"590_CR18","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1242\/jcs.111.21.3167","volume":"111","author":"G Lee","year":"1998","unstructured":"Lee G, Newman ST, Gard DL, Band H, Panchamoorthy G. tau interacts with Src-family non-receptor tyrosine kinases. J Cell Sci. 1998;111(Pt 21):3167\u201377.","journal-title":"J Cell Sci"},{"issue":"42","key":"590_CR19","doi-asserted-by":"publisher","first-page":"35119","DOI":"10.1074\/jbc.M505895200","volume":"280","author":"K Bhaskar","year":"2005","unstructured":"Bhaskar K, Yen SH, Lee G. Disease-related modifications in tau affect the interaction between Fyn and tau. J Biol Chem. 2005;280(42):35119\u201325.","journal-title":"J Biol Chem"},{"key":"590_CR20","doi-asserted-by":"crossref","unstructured":"Padmanabhan P, Mart\u00ednez-M\u00e1rmol R, Xia D, G\u00f6tz J, Meunier FA. Frontotemporal dementia mutant tau promotes aberrant Fyn nanoclustering in hippocampal dendritic spines. Elife. 2019;8.","DOI":"10.7554\/eLife.45040"},{"issue":"1","key":"590_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40478-016-0317-4","volume":"4","author":"DH Lau","year":"2016","unstructured":"Lau DH, Hogseth M, Phillips EC, O\u2019Neill MJ, Pooler AM, Noble W, et al. Critical residues involved in tau binding to Fyn: implications for tau phosphorylation in Alzheimer\u2019s disease. Acta Neuropathol Commun. 2016;4(1):49.","journal-title":"Acta Neuropathol Commun"},{"issue":"Pt 3","key":"590_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2025.117401","volume":"242","author":"X Fan","year":"2025","unstructured":"Fan X, Wang H, Ping J, Li M, Gu J, Qian W. Synaptic scaffold protein PSD-95: a therapeutic target for Alzheimer\u2019s disease. Biochem Pharmacol. 2025;242(Pt 3):117401.","journal-title":"Biochem Pharmacol"},{"issue":"38","key":"590_CR23","doi-asserted-by":"publisher","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","volume":"287","author":"S Mondrag\u00f3n-Rodr\u00edguez","year":"2012","unstructured":"Mondrag\u00f3n-Rodr\u00edguez S, Trillaud-Doppia E, Dudilot A, Bourgeois C, Lauzon M, Leclerc N, et al. Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J Biol Chem. 2012;287(38):32040\u201353.","journal-title":"J Biol Chem"},{"issue":"7","key":"590_CR24","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/iub.467","volume":"63","author":"A Ittner","year":"2011","unstructured":"Ittner A, Ke YD, van Eersel J, Gladbach A, G\u00f6tz J, Ittner LM. Brief update on different roles of tau in neurodegeneration. IUBMB Life. 2011;63(7):495\u2013502.","journal-title":"IUBMB Life"},{"issue":"9","key":"590_CR25","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1523\/JNEUROSCI.4162-03.2004","volume":"24","author":"G Lee","year":"2004","unstructured":"Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, et al. Phosphorylation of tau by Fyn: implications for Alzheimer\u2019s disease. J Neurosci. 2004;24(9):2304\u201312.","journal-title":"J Neurosci"},{"issue":"8","key":"590_CR26","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/90498","volume":"4","author":"KW Roche","year":"2001","unstructured":"Roche KW, Standley S, McCallum J, Dune Ly C, Ehlers MD, Wenthold RJ. Molecular determinants of NMDA receptor internalization. Nat Neurosci. 2001;4(8):794\u2013802.","journal-title":"Nat Neurosci"},{"issue":"6","key":"590_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0028-3908(03)00308-3","volume":"45","author":"G Lavezzari","year":"2003","unstructured":"Lavezzari G, McCallum J, Lee R, Roche KW. Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression. Neuropharmacology. 2003;45(6):729\u201337.","journal-title":"Neuropharmacology"},{"issue":"4","key":"590_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrn1368","volume":"5","author":"MW Salter","year":"2004","unstructured":"Salter MW, Kalia LV. Src kinases: a hub for NMDA receptor regulation. Nat Rev Neurosci. 2004;5(4):317\u201328.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"590_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F, et al. Amyloid-\u03b2\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer\u2019s disease. J Neurosci. 2011;31(2):700\u201311.","journal-title":"J Neurosci"},{"issue":"5","key":"590_CR30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","volume":"79","author":"JW Um","year":"2013","unstructured":"Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, et al. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer A\u03b2 oligomer bound to cellular prion protein. Neuron. 2013;79(5):887\u2013902.","journal-title":"Neuron"},{"issue":"22","key":"590_CR31","doi-asserted-by":"publisher","first-page":"9498","DOI":"10.1523\/JNEUROSCI.5397-12.2013","volume":"33","author":"JF Abisambra","year":"2013","unstructured":"Abisambra JF, Jinwal UK, Blair LJ, O\u2019Leary JC 3rd, Li Q, Brady S, et al. tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation. J Neurosci. 2013;33(22):9498\u2013507.","journal-title":"J Neurosci"},{"issue":"6","key":"590_CR32","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/febs.14332","volume":"285","author":"Y Gerakis","year":"2018","unstructured":"Gerakis Y, Hetz C. Emerging roles of ER stress in the etiology and pathogenesis of Alzheimer\u2019s disease. FEBS J. 2018;285(6):995\u20131011.","journal-title":"FEBS J"},{"issue":"2","key":"590_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00401-005-1038-0","volume":"110","author":"JJ Hoozemans","year":"2005","unstructured":"Hoozemans JJ, Veerhuis R, Van Haastert ES, Rozemuller JM, Baas F, Eikelenboom P, et al. The unfolded protein response is activated in Alzheimer\u2019s disease. Acta Neuropathol. 2005;110(2):165\u201372.","journal-title":"Acta Neuropathol"},{"issue":"9","key":"590_CR34","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nn.3486","volume":"16","author":"T Ma","year":"2013","unstructured":"Ma T, Trinh MA, Wexler AJ, Bourbon C, Gatti E, Pierre P, et al. Suppression of eIF2\u03b1 kinases alleviates Alzheimer\u2019s disease-related plasticity and memory deficits. Nat Neurosci. 2013;16(9):1299\u2013305.","journal-title":"Nat Neurosci"},{"issue":"9","key":"590_CR35","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","volume":"15","author":"JW Um","year":"2012","unstructured":"Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A, et al. Alzheimer amyloid-\u03b2 oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci. 2012;15(9):1227\u201335.","journal-title":"Nat Neurosci"},{"issue":"1","key":"590_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-020-00979-6","volume":"8","author":"G Liu","year":"2020","unstructured":"Liu G, Fiock KL, Levites Y, Golde TE, Hefti MM, Lee G. Fyn depletion ameliorates tau(P301L)-induced neuropathology. Acta Neuropathol Commun. 2020;8(1):108.","journal-title":"Acta Neuropathol Commun"},{"issue":"5090","key":"590_CR37","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1126\/science.1361685","volume":"258","author":"SG Grant","year":"1992","unstructured":"Grant SG, O\u2019Dell TJ, Karl KA, Stein PL, Soriano P, Kandel ER. Impaired long-term potentiation, spatial learning, and hippocampal development in Fyn mutant mice. Science. 1992;258(5090):1903\u201310.","journal-title":"Science"},{"issue":"9","key":"590_CR38","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1073\/pnas.94.9.4761","volume":"94","author":"N Kojima","year":"1997","unstructured":"Kojima N, Wang J, Mansuy IM, Grant SG, Mayford M, Kandel ER. Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. Proc Natl Acad Sci U S A. 1997;94(9):4761\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"590_CR39","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S1357-2725(98)00089-2","volume":"30","author":"MD Resh","year":"1998","unstructured":"Resh MD. Fyn, a Src family tyrosine kinase. Int J Biochem Cell Biol. 1998;30(11):1159\u201362.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"590_CR40","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0092-8674(94)90104-X","volume":"76","author":"MD Resh","year":"1994","unstructured":"Resh MD. Myristylation and palmitylation of Src family members: the fats of the matter. Cell. 1994;76(3):411\u20133.","journal-title":"Cell"},{"key":"590_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fgene.2014.00181","volume":"5","author":"I Amata","year":"2014","unstructured":"Amata I, Maffei M, Pons M. Phosphorylation of unique domains of Src family kinases. Front Genet. 2014;5:181.","journal-title":"Front Genet"},{"issue":"4","key":"590_CR42","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bbrc.2004.09.171","volume":"324","author":"R Roskoski Jr","year":"2004","unstructured":"Roskoski R Jr. Src protein-tyrosine kinase structure and regulation. Biochem Biophys Res Commun. 2004;324(4):1155\u201364.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6617","key":"590_CR43","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/385595a0","volume":"385","author":"W Xu","year":"1997","unstructured":"Xu W, Harrison SC, Eck MJ. Three-dimensional structure of the tyrosine kinase c-Src. Nature. 1997;385(6617):595\u2013602.","journal-title":"Nature"},{"issue":"10","key":"590_CR44","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.7150\/ijbs.5141","volume":"8","author":"M Okada","year":"2012","unstructured":"Okada M. Regulation of the SRC family kinases by Csk. Int J Biol Sci. 2012;8(10):1385\u201397.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"590_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41531-023-00456-6","volume":"9","author":"H Pan","year":"2023","unstructured":"Pan H, Liu Z, Ma J, Li Y, Zhao Y, Zhou X, et al. Genome-wide association study using whole-genome sequencing identifies risk loci for Parkinson\u2019s disease in Chinese population. NPJ Parkinsons Dis. 2023;9(1):22.","journal-title":"NPJ Parkinsons Dis"},{"issue":"7","key":"590_CR46","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ajmg.b.32094","volume":"159B","author":"LM Bekris","year":"2012","unstructured":"Bekris LM, Millard S, Lutz F, Li G, Galasko DR, Farlow MR, et al. tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer\u2019s disease. Am J Med Genet B Neuropsychiatr Genet. 2012;159B(7):874\u201383.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"590_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neurobiolaging.2016.11.001","volume":"51","author":"JA Zahratka","year":"2017","unstructured":"Zahratka JA, Shao Y, Shaw M, Todd K, Formica SV, Khrestian M, et al. Regulatory region genetic variation is associated with FYN expression in Alzheimer\u2019s disease. Neurobiol Aging. 2017;51:43\u201353.","journal-title":"Neurobiol Aging"},{"key":"590_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neulet.2014.05.020","volume":"575","author":"J Li","year":"2014","unstructured":"Li J, Zhou HD, Deng J, Zhu J, Li L, Zhang M, et al. The association of single nucleotide polymorphism of the Fyn gene with sporadic Alzheimer\u2019s disease in the Chinese Han population. Neurosci Lett. 2014;575:80\u20134.","journal-title":"Neurosci Lett"},{"issue":"2","key":"590_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14416","volume":"21","author":"D Yi","year":"2025","unstructured":"Yi D, Byun MS, Park JH, Kim JW, Jung G, Ahn H, et al. tau pathway-based gene analysis on PET identifies CLU and FYN in a Korean cohort. Alzheimers Dement. 2025;21(2):e14416.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"590_CR50","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/jnc.13429","volume":"136","author":"C Lee","year":"2016","unstructured":"Lee C, Low CY, Francis PT, Attems J, Wong PT, Lai MK, et al. An isoform-specific role of FynT tyrosine kinase in Alzheimer\u2019s disease. J Neurochem. 2016;136(3):637\u201350.","journal-title":"J Neurochem"},{"issue":"2","key":"590_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/bpa.12917","volume":"31","author":"CYB Low","year":"2021","unstructured":"Low CYB, Lee JH, Lim FTW, Lee C, Ballard C, Francis PT, et al. Isoform-specific upregulation of FynT kinase expression is associated with tauopathy and glial activation in Alzheimer\u2019s disease and Lewy body dementias. Brain Pathol. 2021;31(2):253\u201366.","journal-title":"Brain Pathol"},{"issue":"2","key":"590_CR52","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1073\/pnas.96.2.435","volume":"96","author":"T Tezuka","year":"1999","unstructured":"Tezuka T, Umemori H, Akiyama T, Nakanishi S, Yamamoto T. PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A. Proc Natl Acad Sci U S A. 1999;96(2):435\u201340.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"590_CR53","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1146\/annurev.cellbio.13.1.513","volume":"13","author":"SM Thomas","year":"1997","unstructured":"Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997;13:513\u2013609.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6463","key":"590_CR54","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/367572a0","volume":"367","author":"H Umemori","year":"1994","unstructured":"Umemori H, Sato S, Yagi T, Aizawa S, Yamamoto T. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature. 1994;367(6463):572\u20136.","journal-title":"Nature"},{"issue":"19","key":"590_CR55","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1523\/JNEUROSCI.20-19-07430.2000","volume":"20","author":"K Biffiger","year":"2000","unstructured":"Biffiger K, Bartsch S, Montag D, Aguzzi A, Schachner M, Bartsch U. Severe hypomyelination of the murine CNS in the absence of myelin-associated glycoprotein and Fyn tyrosine kinase. J Neurosci. 2000;20(19):7430\u20137.","journal-title":"J Neurosci"},{"issue":"4","key":"590_CR56","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1083\/jcb.200706164","volume":"181","author":"R White","year":"2008","unstructured":"White R, Gonsior C, Kr\u00e4mer-Albers EM, St\u00f6hr N, H\u00fcttelmaier S, Trotter J. Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2-dependent RNA granules. J Cell Biol. 2008;181(4):579\u201386.","journal-title":"J Cell Biol"},{"issue":"41","key":"590_CR57","doi-asserted-by":"publisher","first-page":"29042","DOI":"10.1074\/jbc.274.41.29042","volume":"274","author":"EM Kr\u00e4mer","year":"1999","unstructured":"Kr\u00e4mer EM, Klein C, Koch T, Boytinck M, Trotter J. Compartmentation of Fyn kinase with glycosylphosphatidylinositol-anchored molecules in oligodendrocytes facilitates kinase activation during myelination. J Biol Chem. 1999;274(41):29042\u20139.","journal-title":"J Biol Chem"},{"issue":"3","key":"590_CR58","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1523\/JNEUROSCI.22-03-00698.2002","volume":"22","author":"C Klein","year":"2002","unstructured":"Klein C, Kramer EM, Cardine AM, Schraven B, Brandt R, Trotter J. Process outgrowth of oligodendrocytes is promoted by interaction of Fyn kinase with the cytoskeletal protein tau. J Neurosci. 2002;22(3):698\u2013707.","journal-title":"J Neurosci"},{"issue":"6","key":"590_CR59","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1523\/JNEUROSCI.21-06-02039.2001","volume":"21","author":"BR Sperber","year":"2001","unstructured":"Sperber BR, Boyle-Walsh EA, Engleka MJ, Gadue P, Peterson AC, Stein PL, et al. A unique role for Fyn in CNS myelination. J Neurosci. 2001;21(6):2039\u201347.","journal-title":"J Neurosci"},{"issue":"4","key":"590_CR60","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.tins.2019.01.002","volume":"42","author":"B Elbaz","year":"2019","unstructured":"Elbaz B, Popko B. Molecular control of oligodendrocyte development. Trends Neurosci. 2019;42(4):263\u201377.","journal-title":"Trends Neurosci"},{"issue":"33","key":"590_CR61","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1523\/JNEUROSCI.1482-08.2008","volume":"28","author":"Y Miyamoto","year":"2008","unstructured":"Miyamoto Y, Yamauchi J, Tanoue A. Cdk5 phosphorylation of WAVE2 regulates oligodendrocyte precursor cell migration through nonreceptor tyrosine kinase Fyn. J Neurosci. 2008;28(33):8326\u201337.","journal-title":"J Neurosci"},{"issue":"32","key":"590_CR62","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1523\/JNEUROSCI.5319-03.2004","volume":"24","author":"X Liang","year":"2004","unstructured":"Liang X, Draghi NA, Resh MD. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci. 2004;24(32):7140\u20139.","journal-title":"J Neurosci"},{"issue":"3","key":"590_CR63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0092-8674(92)90164-8","volume":"70","author":"AJ Ridley","year":"1992","unstructured":"Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein Rac regulates growth factor-induced membrane ruffling. Cell. 1992;70(3):401\u201310.","journal-title":"Cell"},{"issue":"6","key":"590_CR64","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1083\/jcb.145.6.1209","volume":"145","author":"DJ Osterhout","year":"1999","unstructured":"Osterhout DJ, Wolven A, Wolf RM, Resh MD, Chao MV. Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase. J Cell Biol. 1999;145(6):1209\u201318.","journal-title":"J Cell Biol"},{"issue":"1","key":"590_CR65","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6(1):22.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"590_CR66","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.neurobiolaging.2009.08.007","volume":"32","author":"G Bartzokis","year":"2011","unstructured":"Bartzokis G. Alzheimer\u2019s disease as homeostatic responses to age-related myelin breakdown. Neurobiol Aging. 2011;32(8):1341\u201371.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"590_CR67","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.3390\/ijms21124444","volume":"21","author":"C Matrone","year":"2020","unstructured":"Matrone C, Petrillo F, Nasso R, Ferretti G. Fyn tyrosine kinase as harmonizing factor in neuronal functions and dysfunctions. Int J Mol Sci. 2020;21(12):4444.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"590_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt238","volume":"6","author":"HB Nygaard","year":"2014","unstructured":"Nygaard HB, van Dyck CH, Strittmatter SM. Fyn kinase inhibition as a novel therapy for Alzheimer\u2019s disease. Alzheimers Res Ther. 2014;6(1):8.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"590_CR69","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1742-4658.2011.08391.x","volume":"279","author":"CH Trepanier","year":"2012","unstructured":"Trepanier CH, Jackson MF, MacDonald JF. Regulation of NMDA receptors by the tyrosine kinase Fyn. FEBS J. 2012;279(1):12\u20139.","journal-title":"FEBS J"},{"issue":"1","key":"590_CR70","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1074\/jbc.M008085200","volume":"276","author":"T Nakazawa","year":"2001","unstructured":"Nakazawa T, Komai S, Tezuka T, Hisatsune C, Umemori H, Semba K, et al. Characterization of Fyn-mediated tyrosine phosphorylation sites on GluR epsilon 2 (NR2B) subunit of the N-methyl-D-aspartate receptor. J Biol Chem. 2001;276(1):693\u20139.","journal-title":"J Biol Chem"},{"key":"590_CR71","doi-asserted-by":"crossref","unstructured":"Koster KP, Francesconi W, Berton F, Alahmadi S, Srinivas R, Yoshii A. Developmental NMDA receptor dysregulation in the infantile neuronal ceroid lipofuscinosis mouse model. Elife. 2019;8.","DOI":"10.7554\/eLife.40316"},{"issue":"11","key":"590_CR72","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41583-022-00624-2","volume":"23","author":"R Yasuda","year":"2022","unstructured":"Yasuda R, Hayashi Y, Hell JW. CaMKII: a central molecular organizer of synaptic plasticity, learning and memory. Nat Rev Neurosci. 2022;23(11):666\u201382.","journal-title":"Nat Rev Neurosci"},{"issue":"1-3","key":"590_CR73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.schres.2014.10.020","volume":"167","author":"AC Mitchell","year":"2015","unstructured":"Mitchell AC, Jiang Y, Peter C, Akbarian S. Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophrenia. Schizophr Res. 2015;167(1\u20133):28\u201334.","journal-title":"Schizophr Res"},{"issue":"6","key":"590_CR74","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/jnr.23690","volume":"94","author":"EM Prager","year":"2016","unstructured":"Prager EM, Bergstrom HC, Wynn GH, Braga MF. The basolateral amygdala \u03b3-aminobutyric acidergic system in health and disease. J Neurosci Res. 2016;94(6):548\u201367.","journal-title":"J Neurosci Res"},{"issue":"5","key":"590_CR75","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ceca.2006.01.005","volume":"39","author":"JE Cohen","year":"2006","unstructured":"Cohen JE, Fields RD. CaMKII inactivation by extracellular Ca2+ depletion in dorsal root ganglion neurons. Cell Calcium. 2006;39(5):445\u201354.","journal-title":"Cell Calcium"},{"key":"590_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.855752","volume":"15","author":"AG Mohanan","year":"2022","unstructured":"Mohanan AG, Gunasekaran S, Jacob RS, Omkumar RV. Role of Ca2+\/calmodulin-dependent protein kinase type II in mediating function and dysfunction at glutamatergic synapses. Front Mol Neurosci. 2022;15:855752.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"590_CR77","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","volume":"460","author":"A Lau","year":"2010","unstructured":"Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460(2):525\u201342.","journal-title":"Pflugers Arch"},{"issue":"4","key":"590_CR78","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/aps.2009.24","volume":"30","author":"XX Dong","year":"2009","unstructured":"Dong XX, Wang Y, Qin ZH. Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol Sin. 2009;30(4):379\u201387.","journal-title":"Acta Pharmacol Sin"},{"key":"590_CR79","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuroscience.2017.03.032","volume":"352","author":"Y Huang","year":"2017","unstructured":"Huang Y, Li G, An L, Fan Y, Cheng X, Li X, et al. Fyn regulates multipolar-bipolar transition and neurite morphogenesis of migrating neurons in the developing neocortex. Neuroscience. 2017;352:39\u201351.","journal-title":"Neuroscience"},{"issue":"5","key":"590_CR80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0896-6273(02)00857-7","volume":"35","author":"Y Sasaki","year":"2002","unstructured":"Sasaki Y, Cheng C, Uchida Y, Nakajima O, Ohshima T, Yagi T, et al. Fyn and Cdk5 mediate semaphorin-3A signaling, which is involved in regulation of dendrite orientation in cerebral cortex. Neuron. 2002;35(5):907\u201320.","journal-title":"Neuron"},{"issue":"27","key":"590_CR81","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1523\/JNEUROSCI.1476-04.2004","volume":"24","author":"C Li","year":"2004","unstructured":"Li C, Sasaki Y, Takei K, Yamamoto H, Shouji M, Sugiyama Y, et al. Correlation between semaphorin3A-induced facilitation of axonal transport and local activation of a translation initiation factor eukaryotic translation initiation factor 4E. J Neurosci. 2004;24(27):6161\u201370.","journal-title":"J Neurosci"},{"issue":"16","key":"590_CR82","doi-asserted-by":"publisher","first-page":"7586","DOI":"10.1073\/pnas.0914514107","volume":"107","author":"K Namekata","year":"2010","unstructured":"Namekata K, Harada C, Taya C, Guo X, Kimura H, Parada LF, et al. Dock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex. Proc Natl Acad Sci U S A. 2010;107(16):7586\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"590_CR83","doi-asserted-by":"publisher","first-page":"9174","DOI":"10.1523\/JNEUROSCI.5942-08.2009","volume":"29","author":"LS Laursen","year":"2009","unstructured":"Laursen LS, Chan CW, Ffrench-Constant C. An integrin-contactin complex regulates CNS myelination by differential Fyn phosphorylation. J Neurosci. 2009;29(29):9174\u201385.","journal-title":"J Neurosci"},{"issue":"1","key":"590_CR84","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12916-023-02930-7","volume":"21","author":"W Li","year":"2023","unstructured":"Li W, Pang Y, Wang Y, Mei F, Guo M, Wei Y, et al. Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer\u2019s disease. BMC Med. 2023;21(1):223.","journal-title":"BMC Med"},{"issue":"7","key":"590_CR85","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1523\/JNEUROSCI.5927-11.2012","volume":"32","author":"K Shahpasand","year":"2012","unstructured":"Shahpasand K, Uemura I, Saito T, Asano T, Hata K, Shibata K, et al. Regulation of mitochondrial transport and inter-microtubule spacing by tau phosphorylation at the sites hyperphosphorylated in Alzheimer\u2019s disease. J Neurosci. 2012;32(7):2430\u201341.","journal-title":"J Neurosci"},{"issue":"3","key":"590_CR86","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.201407065","volume":"209","author":"KA Vossel","year":"2015","unstructured":"Vossel KA, Xu JC, Fomenko V, Miyamoto T, Suberbielle E, Knox JA, et al. Tau reduction prevents A\u03b2-induced axonal transport deficits by blocking activation of GSK3\u03b2. J Cell Biol. 2015;209(3):419\u201333.","journal-title":"J Cell Biol"},{"issue":"18","key":"590_CR87","doi-asserted-by":"publisher","first-page":"4859","DOI":"10.1523\/JNEUROSCI.4587-06.2007","volume":"27","author":"DB Pereira","year":"2007","unstructured":"Pereira DB, Chao MV. The tyrosine kinase Fyn determines the localization of TrkB receptors in lipid rafts. J Neurosci. 2007;27(18):4859\u201369.","journal-title":"J Neurosci"},{"issue":"11","key":"590_CR88","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1007\/s12035-021-02518-3","volume":"58","author":"B Guglietti","year":"2021","unstructured":"Guglietti B, Sivasankar S, Mustafa S, Corrigan F, Collins-Praino LE. Fyn kinase activity and its role in neurodegenerative disease pathology: a potential universal target? Mol Neurobiol. 2021;58(11):5986\u20136005.","journal-title":"Mol Neurobiol"},{"issue":"4","key":"590_CR89","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.biopsych.2017.06.004","volume":"83","author":"HB Nygaard","year":"2018","unstructured":"Nygaard HB. Targeting Fyn kinase in Alzheimer\u2019s disease. Biol Psychiatry. 2018;83(4):369\u201376.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"590_CR90","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.bbrc.2016.08.037","volume":"478","author":"W Liu","year":"2016","unstructured":"Liu W, Zhao J, Lu G. MiR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer\u2019s disease. Biochem Biophys Res Commun. 2016;478(2):852\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"590_CR91","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/jcp.22335","volume":"226","author":"MG Yeo","year":"2011","unstructured":"Yeo MG, Oh HJ, Cho HS, Chun JS, Marcantonio EE, Song WK. Phosphorylation of Ser 21 in Fyn regulates its kinase activity, focal adhesion targeting, and is required for cell migration. J Cell Physiol. 2011;226(1):236\u201347.","journal-title":"J Cell Physiol"},{"key":"590_CR92","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.biochem.013008.092711","volume":"78","author":"Z Lu","year":"2009","unstructured":"Lu Z, Hunter T. Degradation of activated protein kinases by ubiquitination. Annu Rev Biochem. 2009;78:435\u201375.","journal-title":"Annu Rev Biochem"},{"issue":"24","key":"590_CR93","doi-asserted-by":"publisher","first-page":"3926","DOI":"10.1091\/mbc.E16-08-0622","volume":"27","author":"E Gottlieb-Abraham","year":"2016","unstructured":"Gottlieb-Abraham E, Gutman O, Pai GM, Rubio I, Henis YI. The residue at position 5 of the N-terminal region of Src and Fyn modulates their myristoylation, palmitoylation, and membrane interactions. Mol Biol Cell. 2016;27(24):3926\u201336.","journal-title":"Mol Biol Cell"},{"issue":"7","key":"590_CR94","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"590_CR95","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnmol.2017.00273","volume":"10","author":"K Phamluong","year":"2017","unstructured":"Phamluong K, Darcq E, Wu S, Sakhai SA, Ron D. Fyn signaling is compartmentalized to dopamine D1 receptor expressing neurons in the dorsal medial striatum. Front Mol Neurosci. 2017;10:273.","journal-title":"Front Mol Neurosci"},{"issue":"13","key":"590_CR96","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1016\/j.celrep.2017.11.107","volume":"21","author":"J Zhu","year":"2017","unstructured":"Zhu J, Zhou Q, Shang Y, Li H, Peng M, Ke X, et al. Synaptic targeting and function of SAPAPs mediated by phosphorylation-dependent binding to PSD-95 MAGUKs. Cell Rep. 2017;21(13):3781\u201393.","journal-title":"Cell Rep"},{"issue":"7328","key":"590_CR97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature09635","volume":"469","author":"M Ciss\u00e9","year":"2011","unstructured":"Ciss\u00e9 M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B, et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature. 2011;469(7328):47\u201352.","journal-title":"Nature"},{"issue":"7","key":"590_CR98","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1074\/jbc.R115.702704","volume":"291","author":"HH Jarosz-Griffiths","year":"2016","unstructured":"Jarosz-Griffiths HH, Noble E, Rushworth JV, Hooper NM. Amyloid-\u03b2 receptors: the good, the bad, and the prion protein. J Biol Chem. 2016;291(7):3174\u201383.","journal-title":"J Biol Chem"},{"key":"590_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.742065","volume":"15","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G. Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci. 2021;15:742065.","journal-title":"Front Neurosci"},{"issue":"27","key":"590_CR100","doi-asserted-by":"publisher","first-page":"10058","DOI":"10.1523\/JNEUROSCI.0302-15.2015","volume":"35","author":"N Panicker","year":"2015","unstructured":"Panicker N, Saminathan H, Jin H, Neal M, Harischandra DS, Gordon R, et al. Fyn kinase regulates microglial neuroinflammatory responses in cell culture and animal models of Parkinson\u2019s disease. J Neurosci. 2015;35(27):10058\u201377.","journal-title":"J Neurosci"},{"issue":"7638","key":"590_CR101","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"1","key":"590_CR102","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1046\/j.1471-4159.1998.71010106.x","volume":"71","author":"Y Iwasaki","year":"1998","unstructured":"Iwasaki Y, Gay B, Wada K, Koizumi S. Association of the Src family tyrosine kinase Fyn with TrkB. J Neurochem. 1998;71(1):106\u201311.","journal-title":"J Neurochem"},{"issue":"28","key":"590_CR103","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202504292","volume":"64","author":"R Tira","year":"2025","unstructured":"Tira R, Leo G, Prandini L, Barracchia CG, D\u2019Onofrio M, Mollica L, et al. Multiple and alternative sites make tau protein an adaptable sticky surface for the SH3 domain of Fyn kinase. Angew Chem Int Ed Engl. 2025;64(28):e202504292.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"590_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108045","volume":"32","author":"A Briner","year":"2020","unstructured":"Briner A, G\u00f6tz J, Polanco JC. Fyn kinase controls tau aggregation in vivo. Cell Rep. 2020;32(7):108045.","journal-title":"Cell Rep"},{"issue":"1","key":"590_CR105","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molcel.2016.05.042","volume":"63","author":"CW Pak","year":"2016","unstructured":"Pak CW, Kosno M, Holehouse AS, Padrick SB, Mittal A, Ali R, et al. Sequence determinants of intracellular phase separation by complex coacervation of a disordered protein. Mol Cell. 2016;63(1):72\u201385.","journal-title":"Mol Cell"},{"key":"590_CR106","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cis.2016.07.003","volume":"239","author":"Y Jho","year":"2017","unstructured":"Jho Y, Yoo HY, Lin Y, Han S, Hwang DS. Molecular and structural basis of low interfacial energy of complex coacervates in water. Adv Colloid Interface Sci. 2017;239:61\u201373.","journal-title":"Adv Colloid Interface Sci"},{"key":"590_CR107","doi-asserted-by":"crossref","unstructured":"Zhang X, Vigers M, McCarty J, Rauch JN, Fredrickson GH, Wilson MZ, et al. The proline-rich domain promotes tau liquid-liquid phase separation in cells. J Cell Biol. 2020; 219(11).","DOI":"10.1083\/jcb.202006054"},{"issue":"2","key":"590_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000034","volume":"7","author":"MD Mukrasch","year":"2009","unstructured":"Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, Griesinger C, et al. Structural polymorphism of 441-residue tau at single residue resolution. PLoS Biol. 2009;7(2):e34.","journal-title":"PLoS Biol"},{"key":"590_CR109","doi-asserted-by":"crossref","unstructured":"Wegmann S, Eftekharzadeh B, Tepper K, Zoltowska KM, Bennett RE, Dujardin S, et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J. 2018;37(7).","DOI":"10.15252\/embj.201798049"},{"issue":"1","key":"590_CR110","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.cell.2015.09.015","volume":"163","author":"A Molliex","year":"2015","unstructured":"Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163(1):123\u201333.","journal-title":"Cell"},{"issue":"4","key":"590_CR111","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.neuron.2015.10.030","volume":"88","author":"T Murakami","year":"2015","unstructured":"Murakami T, Qamar S, Lin JQ, Schierle GS, Rees E, Miyashita A, et al. ALS\/FTD mutation-induced phase transition of FUS liquid droplets and reversible hydrogels into irreversible hydrogels impairs RNP granule function. Neuron. 2015;88(4):678\u201390.","journal-title":"Neuron"},{"issue":"5","key":"590_CR112","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cell.2015.07.047","volume":"162","author":"A Patel","year":"2015","unstructured":"Patel A, Lee HO, Jawerth L, Maharana S, Jahnel M, Hein MY, et al. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162(5):1066\u201377.","journal-title":"Cell"},{"issue":"2","key":"590_CR113","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41380-022-01825-y","volume":"28","author":"R Mart\u00ednez-M\u00e1rmol","year":"2023","unstructured":"Mart\u00ednez-M\u00e1rmol R, Small C, Jiang A, Palliyaguru T, Wallis TP, Gormal RS, et al. Fyn nanoclustering requires switching to an open conformation and is enhanced by FTLD-tau biomolecular condensates. Mol Psychiatry. 2023;28(2):946\u201362.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"590_CR114","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.bpj.2020.01.041","volume":"118","author":"G Hilzenrat","year":"2020","unstructured":"Hilzenrat G, Pand\u017ei\u0107 E, Yang Z, Nieves DJ, Goyette J, Rossy J, et al. Conformational states control Lck switching between free and confined diffusion modes in T cells. Biophys J. 2020;118(6):1489\u2013501.","journal-title":"Biophys J"},{"issue":"2","key":"590_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.166731","volume":"433","author":"Y Lin","year":"2021","unstructured":"Lin Y, Fichou Y, Longhini AP, Llanes LC, Yin P, Bazan GC, et al. Liquid-liquid phase separation of tau driven by hydrophobic interaction facilitates fibrillization of tau. J Mol Biol. 2021;433(2):166731.","journal-title":"J Mol Biol"},{"issue":"33","key":"590_CR116","doi-asserted-by":"publisher","first-page":"13056","DOI":"10.1021\/jacs.1c03078","volume":"143","author":"J Wen","year":"2021","unstructured":"Wen J, Hong L, Krainer G, Yao QQ, Knowles TPJ, Wu S, et al. Conformational expansion of tau in condensates promotes irreversible aggregation. J Am Chem Soc. 2021;143(33):13056\u201364.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"590_CR117","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2017.05.026","volume":"95","author":"AN Shrivastava","year":"2017","unstructured":"Shrivastava AN, Aperia A, Melki R, Triller A. Physico-pathologic mechanisms involved in neurodegeneration: misfolded protein-plasma membrane interactions. Neuron. 2017;95(1):33\u201350.","journal-title":"Neuron"},{"issue":"12","key":"590_CR118","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41583-021-00531-y","volume":"22","author":"P Padmanabhan","year":"2021","unstructured":"Padmanabhan P, Kneynsberg A, G\u00f6tz J. Super-resolution microscopy: a closer look at synaptic dysfunction in Alzheimer disease. Nat Rev Neurosci. 2021;22(12):723\u201340.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"590_CR119","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neuron.2013.02.003","volume":"78","author":"G Mairet-Coello","year":"2013","unstructured":"Mairet-Coello G, Courchet J, Pieraut S, Courchet V, Maximov A, Polleux F. The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of A\u03b2 oligomers through tau phosphorylation. Neuron. 2013;78(1):94\u2013108.","journal-title":"Neuron"},{"issue":"1","key":"590_CR120","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, et al. The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener. 2021;10(1):45.","journal-title":"Transl Neurodegener"},{"issue":"1","key":"590_CR121","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1515\/tnsci-2015-0023","volume":"6","author":"S Jadhav","year":"2015","unstructured":"Jadhav S, Cubinkova V, Zimova I, Brezovakova V, Madari A, Cigankova V, et al. Tau-mediated synaptic damage in Alzheimer\u2019s disease. Transl Neurosci. 2015;6(1):214\u201326.","journal-title":"Transl Neurosci"},{"issue":"5","key":"590_CR122","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/alz.12453","volume":"18","author":"BP Imbimbo","year":"2022","unstructured":"Imbimbo BP, Ippati S, Watling M, Balducci C. A critical appraisal of tau-targeting therapies for primary and secondary tauopathies. Alzheimers Dement. 2022;18(5):1008\u201337.","journal-title":"Alzheimers Dement"},{"issue":"17","key":"590_CR123","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1523\/JNEUROSCI.4261-13.2014","volume":"34","author":"ML Frandemiche","year":"2014","unstructured":"Frandemiche ML, De Seranno S, Rush T, Borel E, Elie A, Arnal I, et al. Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers. J Neurosci. 2014;34(17):6084\u201397.","journal-title":"J Neurosci"},{"issue":"5421","key":"590_CR124","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1126\/science.284.5421.1845","volume":"284","author":"R Sattler","year":"1999","unstructured":"Sattler R, Xiong Z, Lu WY, Hafner M, MacDonald JF, Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science. 1999;284(5421):1845\u20138.","journal-title":"Science"},{"issue":"1","key":"590_CR125","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12035-024-04286-2","volume":"62","author":"S Meur","year":"2025","unstructured":"Meur S, Karati D. Fyn kinase in Alzheimer\u2019s disease: unraveling molecular mechanisms and therapeutic implications. Mol Neurobiol. 2025;62(1):643\u201360.","journal-title":"Mol Neurobiol"},{"key":"590_CR126","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.csbj.2022.11.049","volume":"21","author":"CA Crossley","year":"2023","unstructured":"Crossley CA, Rajani V, Yuan Q. Modulation of L-type calcium channels in Alzheimer\u2019s disease: a potential therapeutic target. Comput Struct Biotechnol J. 2023;21:11\u201320.","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"590_CR127","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/nan.12084","volume":"40","author":"S Mondrag\u00f3n-Rodr\u00edguez","year":"2014","unstructured":"Mondrag\u00f3n-Rodr\u00edguez S, Perry G, Luna-Mu\u00f1oz J, Acevedo-Aquino MC, Williams S. Phosphorylation of tau protein at sites Ser(396\u2013404) is one of the earliest events in Alzheimer\u2019s disease and down syndrome. Neuropathol Appl Neurobiol. 2014;40(2):121\u201335.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"3","key":"590_CR128","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.cell.2010.07.032","volume":"142","author":"C Haass","year":"2010","unstructured":"Haass C, Mandelkow E. Fyn-tau-amyloid: a toxic triad. Cell. 2010;142(3):356\u20138.","journal-title":"Cell"},{"issue":"8","key":"590_CR129","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1002\/alz.13065","volume":"19","author":"EK Webber","year":"2023","unstructured":"Webber EK, Fivaz M, Stutzmann GE, Griffioen G. Cytosolic calcium: judge, jury and executioner of neurodegeneration in Alzheimer\u2019s disease and beyond. Alzheimers Dement. 2023;19(8):3701\u201317.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"590_CR130","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nrn960","volume":"3","author":"FM LaFerla","year":"2002","unstructured":"LaFerla FM. Calcium dyshomeostasis and intracellular signalling in Alzheimer\u2019s disease. Nat Rev Neurosci. 2002;3(11):862\u201372.","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"590_CR131","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bbadis.2014.12.017","volume":"1852","author":"D Xia","year":"2015","unstructured":"Xia D, Li C, G\u00f6tz J. Pseudophosphorylation of tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein tau to dendritic spines. Biochim Biophys Acta. 2015;1852(5):913\u201324.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"590_CR132","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","volume":"181","author":"HC Tai","year":"2012","unstructured":"Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012;181(4):1426\u201335.","journal-title":"Am J Pathol"},{"key":"590_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.757515","volume":"14","author":"PP Guan","year":"2021","unstructured":"Guan PP, Cao LL, Yang Y, Wang P. Calcium ions aggravate Alzheimer\u2019s disease through the aberrant activation of neuronal networks, leading to synaptic and cognitive deficits. Front Mol Neurosci. 2021;14:757515.","journal-title":"Front Mol Neurosci"},{"issue":"16","key":"590_CR134","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1111\/j.1742-4658.2011.08218.x","volume":"278","author":"A Usardi","year":"2011","unstructured":"Usardi A, Pooler AM, Seereeram A, Reynolds CH, Derkinderen P, Anderton B, et al. Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. FEBS J. 2011;278(16):2927\u201337.","journal-title":"FEBS J"},{"key":"590_CR135","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/bs.apha.2017.09.007","volume":"82","author":"AH Brody","year":"2018","unstructured":"Brody AH, Strittmatter SM. Synaptotoxic signaling by amyloid \u03b2 oligomers in Alzheimer\u2019s disease through prion protein and mGluR5. Adv Pharmacol. 2018;82:293\u2013323.","journal-title":"Adv Pharmacol"},{"issue":"1","key":"590_CR136","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-017-0176-x","volume":"12","author":"T Miyamoto","year":"2017","unstructured":"Miyamoto T, Stein L, Thomas R, Djukic B, Taneja P, Knox J, et al. Phosphorylation of tau at Y18, but not tau-Fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture. Mol Neurodegener. 2017;12(1):41.","journal-title":"Mol Neurodegener"},{"issue":"3","key":"590_CR137","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ceca.2009.12.010","volume":"47","author":"E Alberdi","year":"2010","unstructured":"Alberdi E, S\u00e1nchez-G\u00f3mez MV, Cavaliere F, P\u00e9rez-Samart\u00edn A, Zugaza JL, Trullas R, et al. Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium. 2010;47(3):264\u201372.","journal-title":"Cell Calcium"},{"issue":"1","key":"590_CR138","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40035-021-00278-7","volume":"11","author":"M Verma","year":"2022","unstructured":"Verma M, Lizama BN, Chu CT. Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration. Transl Neurodegener. 2022;11(1):3.","journal-title":"Transl Neurodegener"},{"key":"590_CR139","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.redox.2015.08.010","volume":"6","author":"A G\u00f6rlach","year":"2015","unstructured":"G\u00f6rlach A, Bertram K, Hudecova S, Krizanova O. Calcium and ROS: a mutual interplay. Redox Biol. 2015;6:260\u201371.","journal-title":"Redox Biol"},{"issue":"5594","key":"590_CR140","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298(5594):789\u201391.","journal-title":"Science"},{"issue":"6","key":"590_CR141","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/ana.24394","volume":"77","author":"AC Kaufman","year":"2015","unstructured":"Kaufman AC, Salazar SV, Haas LT, Yang J, Kostylev MA, Jeng AT, et al. Fyn inhibition rescues established memory and synapse loss in Alzheimer mice. Ann Neurol. 2015;77(6):953\u201371.","journal-title":"Ann Neurol"},{"issue":"24","key":"590_CR142","doi-asserted-by":"publisher","first-page":"7760","DOI":"10.1111\/febs.16197","volume":"289","author":"CC Portugal","year":"2022","unstructured":"Portugal CC, Almeida TO, Socodato R, Relvas JB. Src family kinases (SFKs): critical regulators of microglial homeostatic functions and neurodegeneration in Parkinson\u2019s and Alzheimer\u2019s diseases. FEBS J. 2022;289(24):7760\u201375.","journal-title":"FEBS J"},{"issue":"1","key":"590_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40263-020-00787-5","volume":"35","author":"MC Gage","year":"2021","unstructured":"Gage MC, Thippeswamy T. Inhibitors of Src family kinases, inducible nitric oxide synthase, and NADPH oxidase as potential CNS drug targets for neurological diseases. CNS Drugs. 2021;35(1):1\u201320.","journal-title":"CNS Drugs"},{"issue":"2","key":"590_CR144","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/glia.23100","volume":"65","author":"N Schneble","year":"2017","unstructured":"Schneble N, M\u00fcller J, Kliche S, Bauer R, Wetzker R, B\u00f6hmer FD, et al. The protein-tyrosine phosphatase DEP-1 promotes migration and phagocytic activity of microglial cells in part through negative regulation of Fyn tyrosine kinase. Glia. 2017;65(2):416\u201328.","journal-title":"Glia"},{"issue":"12","key":"590_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107796","volume":"31","author":"R Socodato","year":"2020","unstructured":"Socodato R, Portugal CC, Canedo T, Rodrigues A, Almeida TO, Henriques JF, et al. Microglia dysfunction caused by the loss of RhoA disrupts neuronal physiology and leads to neurodegeneration. Cell Rep. 2020;31(12):107796.","journal-title":"Cell Rep"},{"issue":"9","key":"590_CR146","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1755-5949.2012.00357.x","volume":"18","author":"CP Du","year":"2012","unstructured":"Du CP, Tan R, Hou XY. Fyn kinases play a critical role in neuronal apoptosis induced by oxygen and glucose deprivation or amyloid-\u03b2 peptide treatment. CNS Neurosci Ther. 2012;18(9):754\u201361.","journal-title":"CNS Neurosci Ther"},{"issue":"7","key":"590_CR147","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0006-2952(98)00124-5","volume":"56","author":"MW Salter","year":"1998","unstructured":"Salter MW. Src, N-methyl-D-aspartate (NMDA) receptors, and synaptic plasticity. Biochem Pharmacol. 1998;56(7):789\u201398.","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"590_CR148","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0896-6273(01)00220-3","volume":"29","author":"Y Huang","year":"2001","unstructured":"Huang Y, Lu W, Ali DW, Pelkey KA, Pitcher GM, Lu YM, et al. CAKbeta\/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron. 2001;29(2):485\u201396.","journal-title":"Neuron"},{"issue":"2","key":"590_CR149","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1006\/bbrc.1995.2662","volume":"216","author":"T Suzuki","year":"1995","unstructured":"Suzuki T, Okumura-Noji K. NMDA receptor subunits epsilon 1 (NR2A) and epsilon 2 (NR2B) are substrates for Fyn in the postsynaptic density fraction isolated from the rat brain. Biochem Biophys Res Commun. 1995;216(2):582\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"590_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108615","volume":"193","author":"V Rajani","year":"2021","unstructured":"Rajani V, Sengar AS, Salter MW. Src and Fyn regulation of NMDA receptors in health and disease. Neuropharmacology. 2021;193:108615.","journal-title":"Neuropharmacology"},{"issue":"6","key":"590_CR151","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0028-3908(03)00313-7","volume":"45","author":"LV Kalia","year":"2003","unstructured":"Kalia LV, Salter MW. Interactions between Src family protein tyrosine kinases and PSD-95. Neuropharmacology. 2003;45(6):720\u20138.","journal-title":"Neuropharmacology"},{"issue":"5300","key":"590_CR152","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1126\/science.275.5300.674","volume":"275","author":"XM Yu","year":"1997","unstructured":"Yu XM, Askalan R, Keil GJ 2nd, Salter MW. NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science. 1997;275(5300):674\u20138.","journal-title":"Science"},{"issue":"3","key":"590_CR153","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0014-5793(00)02169-4","volume":"484","author":"MJ Smith","year":"2000","unstructured":"Smith MJ, Crowther RA, Goedert M. The natural osmolyte trimethylamine N-oxide (TMAO) restores the ability of mutant tau to promote microtubule assembly. FEBS Lett. 2000;484(3):265\u201370.","journal-title":"FEBS Lett"},{"key":"590_CR154","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fneur.2013.00160","volume":"4","author":"KL Gendreau","year":"2013","unstructured":"Gendreau KL, Hall GF. Tangles, toxicity, and tau secretion in AD\u2014new approaches to a vexing problem. Front Neurol. 2013;4:160.","journal-title":"Front Neurol"},{"issue":"41","key":"590_CR155","doi-asserted-by":"publisher","first-page":"12776","DOI":"10.1523\/JNEUROSCI.3463-09.2009","volume":"29","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, Burns M, Binder LI, Kanaan NM, LaPointe N, Bosco DA, et al. Axonal transport defects in neurodegenerative diseases. J Neurosci. 2009;29(41):12776\u201386.","journal-title":"J Neurosci"},{"issue":"8","key":"590_CR156","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/01.jnen.0000228202.35163.c4","volume":"65","author":"TM Wishart","year":"2006","unstructured":"Wishart TM, Parson SH, Gillingwater TH. Synaptic vulnerability in neurodegenerative disease. J Neuropathol Exp Neurol. 2006;65(8):733\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6A","key":"590_CR157","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1111\/j.1582-4934.2008.00402.x","volume":"12","author":"AM Gorman","year":"2008","unstructured":"Gorman AM. Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling. J Cell Mol Med. 2008;12(6A):2263\u201380.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"590_CR158","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/1097-4547(20010301)63:5<377::AID-JNR1032>3.0.CO;2-#","volume":"63","author":"M Urushitani","year":"2001","unstructured":"Urushitani M, Nakamizo T, Inoue R, Sawada H, Kihara T, Honda K, et al. N-methyl-D-aspartate receptor-mediated mitochondrial Ca2+ overload in acute excitotoxic motor neuron death: a mechanism distinct from chronic neurotoxicity after Ca2+ influx. J Neurosci Res. 2001;63(5):377\u201387.","journal-title":"J Neurosci Res"},{"issue":"7","key":"590_CR159","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132604","volume":"10","author":"GD Manocha","year":"2015","unstructured":"Manocha GD, Puig KL, Austin SA, Seyb K, Glicksman MA, Combs CK. Characterization of novel Src family kinase inhibitors to attenuate microgliosis. PLoS ONE. 2015;10(7):e0132604.","journal-title":"PLoS ONE"},{"issue":"10","key":"590_CR160","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.neurobiolaging.2011.10.027","volume":"33","author":"G Dhawan","year":"2012","unstructured":"Dhawan G, Floden AM, Combs CK. Amyloid-\u03b2 oligomers stimulate microglia through a tyrosine kinase dependent mechanism. Neurobiol Aging. 2012;33(10):2247\u201361.","journal-title":"Neurobiol Aging"},{"issue":"48","key":"590_CR161","doi-asserted-by":"publisher","first-page":"7918","DOI":"10.1038\/sj.onc.1208081","volume":"23","author":"TJ Boggon","year":"2004","unstructured":"Boggon TJ, Eck MJ. Structure and regulation of Src family kinases. Oncogene. 2004;23(48):7918\u201327.","journal-title":"Oncogene"},{"issue":"Pt 3","key":"590_CR162","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1042\/bj3030749","volume":"303","author":"M Koegl","year":"1994","unstructured":"Koegl M, Zlatkine P, Ley SC, Courtneidge SA, Magee AI. Palmitoylation of multiple Src-family kinases at a homologous N-terminal motif. Biochem J. 1994;303(Pt 3):749\u201353.","journal-title":"Biochem J"},{"issue":"1","key":"590_CR163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-4889(99)00075-0","volume":"1451","author":"MD Resh","year":"1999","unstructured":"Resh MD. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta. 1999;1451(1):1\u201316.","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 7","key":"590_CR164","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1242\/jcs.034843","volume":"122","author":"I Sato","year":"2009","unstructured":"Sato I, Obata Y, Kasahara K, Nakayama Y, Fukumoto Y, Yamasaki T, et al. Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain. J Cell Sci. 2009;122(Pt 7):965\u201375.","journal-title":"J Cell Sci"},{"issue":"5","key":"590_CR165","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1083\/jcb.200403011","volume":"165","author":"K Kasahara","year":"2004","unstructured":"Kasahara K, Nakayama Y, Ikeda K, Fukushima Y, Matsuda D, Horimoto S, et al. Trafficking of Lyn through the Golgi caveolin involves the charged residues on alphaE and alphaI helices in the kinase domain. J Cell Biol. 2004;165(5):641\u201352.","journal-title":"J Cell Biol"},{"issue":"12","key":"590_CR166","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.yexcr.2007.05.001","volume":"313","author":"K Kasahara","year":"2007","unstructured":"Kasahara K, Nakayama Y, Kihara A, Matsuda D, Ikeda K, Kuga T, et al. Rapid trafficking of c-Src, a non-palmitoylated Src-family kinase, between the plasma membrane and late endosomes\/lysosomes. Exp Cell Res. 2007;313(12):2651\u201366.","journal-title":"Exp Cell Res"},{"key":"590_CR167","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1750-1326-6-12","volume":"6","author":"TM Scales","year":"2011","unstructured":"Scales TM, Derkinderen P, Leung KY, Byers HL, Ward MA, Price C, et al. Tyrosine phosphorylation of tau by the SRC family kinases Lck and Fyn. Mol Neurodegener. 2011;6:12.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"590_CR168","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1084\/jem.20182191","volume":"216","author":"N Panicker","year":"2019","unstructured":"Panicker N, Sarkar S, Harischandra DS, Neal M, Kam TI, Jin H, et al. Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia. J Exp Med. 2019;216(6):1411\u201330.","journal-title":"J Exp Med"},{"issue":"8","key":"590_CR169","first-page":"4195","volume":"130","author":"S Sarkar","year":"2020","unstructured":"Sarkar S, Nguyen HM, Malovic E, Luo J, Langley M, Palanisamy BN, et al. Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson\u2019s disease. J Clin Invest. 2020;130(8):4195\u2013212.","journal-title":"J Clin Invest"},{"issue":"15","key":"590_CR170","doi-asserted-by":"publisher","first-page":"E1926","DOI":"10.1073\/pnas.1417883112","volume":"112","author":"S Wang","year":"2015","unstructured":"Wang S, Chu CH, Stewart T, Ginghina C, Wang Y, Nie H, et al. \u03b1-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation. Proc Natl Acad Sci U S A. 2015;112(15):E1926\u201335.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"590_CR171","doi-asserted-by":"publisher","first-page":"11368","DOI":"10.1038\/s41598-025-96456-y","volume":"15","author":"R Islam","year":"2025","unstructured":"Islam R, Choudhary HH, Zhang F, Mehta H, Yoshida J, Thomas AJ, et al. Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, A\u03b2 phagocytosis, neuronal damage, and cell survival in Alzheimer\u2019s disease. Sci Rep. 2025;15(1):11368.","journal-title":"Sci Rep"},{"issue":"12","key":"590_CR172","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1002\/glia.23522","volume":"66","author":"SL Lim","year":"2018","unstructured":"Lim SL, Tran DN, Zumkehr J, Chen C, Ghiaar S, Kieu Z, et al. Inhibition of hematopoietic cell kinase dysregulates microglial function and accelerates early stage Alzheimer\u2019s disease-like neuropathology. Glia. 2018;66(12):2700\u201318.","journal-title":"Glia"},{"key":"590_CR173","doi-asserted-by":"publisher","first-page":"43651","DOI":"10.1038\/srep43651","volume":"7","author":"C Lee","year":"2017","unstructured":"Lee C, Low CY, Wong SY, Lai MK, Tan MG. Selective induction of alternatively spliced FynT isoform by TNF facilitates persistent inflammatory responses in astrocytes. Sci Rep. 2017;7:43651.","journal-title":"Sci Rep"},{"issue":"4","key":"590_CR174","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-018-01957-y","volume":"137","author":"IC Stancu","year":"2019","unstructured":"Stancu IC, Cremers N, Vanrusselt H, Couturier J, Vanoosthuyse A, Kessels S, et al. Aggregated tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded tau pathology in vivo. Acta Neuropathol. 2019;137(4):599\u2013617.","journal-title":"Acta Neuropathol"},{"key":"590_CR175","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"issue":"45","key":"590_CR176","doi-asserted-by":"publisher","first-page":"16064","DOI":"10.1523\/JNEUROSCI.4158-11.2011","volume":"31","author":"M Tremblay","year":"2011","unstructured":"Tremblay M, Stevens B, Sierra A, Wake H, Bessis A, Nimmerjahn A. The role of microglia in the healthy brain. J Neurosci. 2011;31(45):16064\u20139.","journal-title":"J Neurosci"},{"issue":"1","key":"590_CR177","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther. 2023;8(1):359.","journal-title":"Signal Transduct Target Ther"},{"issue":"34","key":"590_CR178","doi-asserted-by":"publisher","first-page":"8680","DOI":"10.1523\/JNEUROSCI.1771-06.2006","volume":"26","author":"H Katsura","year":"2006","unstructured":"Katsura H, Obata K, Mizushima T, Sakurai J, Kobayashi K, Yamanaka H, et al. Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J Neurosci. 2006;26(34):8680\u201390.","journal-title":"J Neurosci"},{"issue":"14","key":"590_CR179","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00018-012-1015-4","volume":"69","author":"MJ Surace","year":"2012","unstructured":"Surace MJ, Block ML. Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors. Cell Mol Life Sci. 2012;69(14):2409\u201327.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"590_CR180","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0166-2236(98)01349-6","volume":"22","author":"A Araque","year":"1999","unstructured":"Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci. 1999;22(5):208\u201315.","journal-title":"Trends Neurosci"},{"issue":"8","key":"590_CR181","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.tins.2009.05.001","volume":"32","author":"G Perea","year":"2009","unstructured":"Perea G, Navarrete M, Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 2009;32(8):421\u201331.","journal-title":"Trends Neurosci"},{"issue":"5745","key":"590_CR182","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1126\/science.1116916","volume":"310","author":"O Pascual","year":"2005","unstructured":"Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul JY, et al. Astrocytic purinergic signaling coordinates synaptic networks. Science. 2005;310(5745):113\u20136.","journal-title":"Science"},{"issue":"34","key":"590_CR183","doi-asserted-by":"publisher","first-page":"11228","DOI":"10.1523\/JNEUROSCI.0015-14.2014","volume":"34","author":"O Chever","year":"2014","unstructured":"Chever O, Lee CY, Rouach N. Astroglial connexin43 hemichannels tune basal excitatory synaptic transmission. J Neurosci. 2014;34(34):11228\u201332.","journal-title":"J Neurosci"},{"issue":"1","key":"590_CR184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0301-0082(00)00067-8","volume":"65","author":"NC Danbolt","year":"2001","unstructured":"Danbolt NC. Glutamate uptake. Prog Neurobiol. 2001;65(1):1\u2013105.","journal-title":"Prog Neurobiol"},{"key":"590_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108719","volume":"196","author":"JV Andersen","year":"2021","unstructured":"Andersen JV, Markussen KH, Jakobsen E, Schousboe A, Waagepetersen HS, Rosenberg PA, et al. Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology. 2021;196:108719.","journal-title":"Neuropharmacology"},{"issue":"7","key":"590_CR186","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/glia.20374","volume":"54","author":"E Scemes","year":"2006","unstructured":"Scemes E, Giaume C. Astrocyte calcium waves: what they are and what they do. Glia. 2006;54(7):716\u201325.","journal-title":"Glia"},{"issue":"22","key":"590_CR187","doi-asserted-by":"publisher","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","volume":"91","author":"L Pellerin","year":"1994","unstructured":"Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A. 1994;91(22):10625\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"590_CR188","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M B\u00e9langer","year":"2011","unstructured":"B\u00e9langer M, Allaman I, Magistretti PJ. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14(6):724\u201338.","journal-title":"Cell Metab"},{"issue":"5","key":"590_CR189","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","volume":"144","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, et al. Astrocyte-neuron lactate transport is required for long-term memory formation. Cell. 2011;144(5):810\u201323.","journal-title":"Cell"},{"key":"590_CR190","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neuroscience.2017.09.051","volume":"365","author":"Y Wang","year":"2017","unstructured":"Wang Y, Lu S, Qu Z, Wu L, Wang Y. Sonic hedgehog induces GLT-1 degradation via PKC delta to suppress its transporter activities. Neuroscience. 2017;365:217\u201325.","journal-title":"Neuroscience"},{"issue":"7","key":"590_CR191","doi-asserted-by":"publisher","DOI":"10.3390\/cells13070581","volume":"13","author":"T Ageeva","year":"2024","unstructured":"Ageeva T, Rizvanov A, Mukhamedshina Y. NF-\u03baB and JAK\/STAT signaling pathways as crucial regulators of neuroinflammation and astrocyte modulation in spinal cord injury. Cells. 2024;13(7):581.","journal-title":"Cells"},{"issue":"11","key":"590_CR192","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70474","volume":"6","author":"Y Li","year":"2020","unstructured":"Li Y, Jiang Y, Hu Z, Yang S, Li L, Xiong C, et al. Protein kinase C family: structures, biological functions, diseases, and pharmaceutical interventions. MedComm. 2020;6(11):e70474.","journal-title":"MedComm."},{"issue":"1","key":"590_CR193","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.bbrc.2017.11.143","volume":"495","author":"HM Ko","year":"2018","unstructured":"Ko HM, Lee SH, Bang M, Kim KC, Jeon SJ, Park YM, et al. Tyrosine kinase Fyn regulates iNOS expression in LPS-stimulated astrocytes via modulation of ERK phosphorylation. Biochem Biophys Res Commun. 2018;495(1):1214\u201320.","journal-title":"Biochem Biophys Res Commun"},{"issue":"42","key":"590_CR194","doi-asserted-by":"publisher","first-page":"9694","DOI":"10.1523\/JNEUROSCI.2980-05.2005","volume":"25","author":"J Chin","year":"2005","unstructured":"Chin J, Palop JJ, Puoliv\u00e4li J, Massaro C, Bien-Ly N, Gerstein H, et al. Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer\u2019s disease. J Neurosci. 2005;25(42):9694\u2013703.","journal-title":"J Neurosci"},{"issue":"1","key":"590_CR195","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bj.2018.01.003","volume":"41","author":"C Laurent","year":"2018","unstructured":"Laurent C, Bu\u00e9e L, Blum D. Tau and neuroinflammation: what impact for Alzheimer\u2019s disease and tauopathies? Biomed J. 2018;41(1):21\u201333.","journal-title":"Biomed J"},{"issue":"11","key":"590_CR196","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","volume":"33","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA, et al. Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. J Neurosci. 2013;33(11):5053\u201364.","journal-title":"J Neurosci"},{"issue":"7784","key":"590_CR197","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2019","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives tau pathology. Nature. 2019;575(7784):669\u201373.","journal-title":"Nature"},{"issue":"Pt 6","key":"590_CR198","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/brain\/awv081","volume":"138","author":"N Maphis","year":"2015","unstructured":"Maphis N, Xu G, Kokiko-Cochran ON, Jiang S, Cardona A, Ransohoff RM, et al. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain. Brain. 2015;138(Pt 6):1738\u201355.","journal-title":"Brain"},{"issue":"1","key":"590_CR199","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","volume":"295","author":"RA Quintanilla","year":"2004","unstructured":"Quintanilla RA, Orellana DI, Gonz\u00e1lez-Billault C, Maccioni RB. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the Cdk5\/p35 pathway. Exp Cell Res. 2004;295(1):245\u201357.","journal-title":"Exp Cell Res"},{"issue":"23","key":"590_CR200","doi-asserted-by":"publisher","first-page":"10923","DOI":"10.18632\/aging.102495","volume":"11","author":"XY Zheng","year":"2019","unstructured":"Zheng XY, Lv YD, Jin FY, Wu XJ, Zhu J, Ruan Y. Kainic acid hyperphosphorylates tau via inflammasome activation in MAPT transgenic mice. Aging (Albany NY). 2019;11(23):10923\u201338.","journal-title":"Aging (Albany NY)"},{"issue":"12","key":"590_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109720","volume":"36","author":"S Jiang","year":"2021","unstructured":"Jiang S, Maphis NM, Binder J, Chisholm D, Weston L, Duran W, et al. Proteopathic tau primes and activates interleukin-1\u03b2 via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway. Cell Rep. 2021;36(12):109720.","journal-title":"Cell Rep"},{"issue":"4\u20135","key":"590_CR202","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000369995","volume":"37","author":"R Knox","year":"2015","unstructured":"Knox R, Jiang X. Fyn in neurodevelopment and ischemic brain injury. Dev Neurosci. 2015;37(4\u20135):311\u201320.","journal-title":"Dev Neurosci"},{"issue":"2","key":"590_CR203","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mcn.2010.03.002","volume":"44","author":"R Jurd","year":"2010","unstructured":"Jurd R, Tretter V, Walker J, Brandon NJ, Moss SJ. Fyn kinase contributes to tyrosine phosphorylation of the GABA(A) receptor gamma2 subunit. Mol Cell Neurosci. 2010;44(2):129\u201334.","journal-title":"Mol Cell Neurosci"},{"key":"590_CR204","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2016.04.008","volume":"93","author":"R Gordon","year":"2016","unstructured":"Gordon R, Singh N, Lawana V, Ghosh A, Harischandra DS, Jin H, et al. Protein kinase C\u03b4 upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson\u2019s disease. Neurobiol Dis. 2016;93:96\u2013114.","journal-title":"Neurobiol Dis"},{"key":"590_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2022.102306","volume":"216","author":"KF Odfalk","year":"2022","unstructured":"Odfalk KF, Bieniek KF, Hopp SC. Microglia: friend and foe in tauopathy. Prog Neurobiol. 2022;216:102306.","journal-title":"Prog Neurobiol"},{"issue":"5825","key":"590_CR206","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, et al. Reducing endogenous tau ameliorates amyloid \u03b2-induced deficits in an Alzheimer\u2019s disease mouse model. Science. 2007;316(5825):750\u20134.","journal-title":"Science"},{"issue":"1","key":"590_CR207","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-015-0119-0","volume":"7","author":"HB Nygaard","year":"2015","unstructured":"Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA, et al. A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer\u2019s disease. Alzheimers Res Ther. 2015;7(1):35.","journal-title":"Alzheimers Res Ther"},{"key":"590_CR208","doi-asserted-by":"crossref","unstructured":"Lee SE, Tartaglia MC, Yener G, Gen\u00e7 S, Seeley WW, Sanchez-Juan P, et al. Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27(4):302\u20139.","DOI":"10.1097\/WAD.0b013e31828cc357"},{"issue":"9","key":"590_CR209","doi-asserted-by":"publisher","first-page":"2231.e7","DOI":"10.1016\/j.neurobiolaging.2012.04.006","volume":"33","author":"E Kara","year":"2012","unstructured":"Kara E, Ling H, Pittman AM, Shaw K, de Silva R, Simone R, et al. The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobiol Aging. 2012;33(9):2231.e7-14.","journal-title":"Neurobiol Aging"},{"key":"590_CR210","doi-asserted-by":"crossref","unstructured":"Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer\u2019s diseases. Hum Mol Genet. 2012; 21(15):3500\u201312.","DOI":"10.1093\/hmg\/dds161"},{"key":"590_CR211","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.reth.2024.12.009","volume":"28","author":"M Itsuno","year":"2025","unstructured":"Itsuno M, Tanabe H, Sano E, Sasaki T, Oyama C, Bannai H, et al. MAPT-A152T mutation drives neuronal hyperactivity through Fyn-NMDAR signaling in human iPSC-derived neurons: insights into Alzheimer\u2019s pathogenesis. Regen Ther. 2025;28:201\u201313.","journal-title":"Regen Ther"},{"issue":"1","key":"590_CR212","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2023.10.001","volume":"21","author":"JR Roth","year":"2024","unstructured":"Roth JR, Rush T, Thompson SJ, Aldaher AR, Dunn TB, Mesina JS, et al. Development of small-molecule tau-SH3 interaction inhibitors that prevent amyloid-\u03b2 toxicity and network hyperexcitability. Neurotherapeutics. 2024;21(1):e00291.","journal-title":"Neurotherapeutics"},{"key":"590_CR213","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104668","volume":"134","author":"T Rush","year":"2020","unstructured":"Rush T, Roth JR, Thompson SJ, Aldaher AR, Cochran JN, Roberson ED. A peptide inhibitor of tau-SH3 interactions ameliorates amyloid-\u03b2 toxicity. Neurobiol Dis. 2020;134:104668.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"590_CR214","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1006\/bbrc.2000.4253","volume":"280","author":"T Nakamura","year":"2001","unstructured":"Nakamura T, Yamashita H, Takahashi T, Nakamura S. Activated Fyn phosphorylates \u03b1-synuclein at tyrosine residue 125. Biochem Biophys Res Commun. 2001;280(4):1085\u201392.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"590_CR215","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1073\/pnas.1417423112","volume":"112","author":"PK Kurup","year":"2015","unstructured":"Kurup PK, Xu J, Videira RA, Ononenyi C, Baltazar G, Lombroso PJ, et al. STEP61 is a substrate of the E3 ligase parkin and is upregulated in Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2015;112(4):1202\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"590_CR216","doi-asserted-by":"publisher","first-page":"11832","DOI":"10.1523\/JNEUROSCI.3478-07.2007","volume":"27","author":"DV Venkitaramani","year":"2007","unstructured":"Venkitaramani DV, Chin J, Netzer WJ, Gouras GK, Lesne S, Malinow R, et al. Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci. 2007;27(44):11832\u20137.","journal-title":"J Neurosci"},{"issue":"11","key":"590_CR217","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/mds.27478","volume":"33","author":"IC Br\u00e1s","year":"2018","unstructured":"Br\u00e1s IC, Lopes LV, Outeiro TF. Sensing \u03b1-synuclein from the outside via the prion protein: implications for neurodegeneration. Mov Disord. 2018;33(11):1675\u201384.","journal-title":"Mov Disord"},{"issue":"11","key":"590_CR218","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1038\/nn.4648","volume":"20","author":"DG Ferreira","year":"2017","unstructured":"Ferreira DG, Temido-Ferreira M, Vicente Miranda H, Batalha VL, Coelho JE, Szeg\u00f6 \u00c9M, et al. \u03b1-synuclein interacts with PrP(C) to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci. 2017;20(11):1569\u201379.","journal-title":"Nat Neurosci"},{"issue":"5","key":"590_CR219","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1073\/pnas.1618627114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X, Manfredsson FP, He L, Iuvone PM, et al. \u03b1-Synuclein binds and sequesters PIKE-L into Lewy bodies, triggering dopaminergic cell death via AMPK hyperactivation. Proc Natl Acad Sci U S A. 2017;114(5):1183\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"590_CR220","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1073\/pnas.1713969114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X, Manfredsson FP, Benskey MJ, Cao X, et al. TrkB neurotrophic activities are blocked by \u03b1-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2017;114(40):10773\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"590_CR221","doi-asserted-by":"publisher","first-page":"2430193","DOI":"10.1155\/2018\/2430193","volume":"2018","author":"C Mallozzi","year":"2018","unstructured":"Mallozzi C, Spalloni A, Longone P, Domenici MR. Activation of phosphotyrosine-mediated signaling pathways in the cortex and spinal cord of SOD1(G93A), a mouse model of familial amyotrophic lateral sclerosis. Neural Plast. 2018;2018:2430193.","journal-title":"Neural Plast"},{"issue":"1","key":"590_CR222","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12974-016-0620-9","volume":"13","author":"E Trias","year":"2016","unstructured":"Trias E, Ibarburu S, Barreto-N\u00fa\u00f1ez R, Babdor J, Maciel TT, Guillo M, et al. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J Neuroinflammation. 2016;13(1):177.","journal-title":"J Neuroinflammation"},{"issue":"18","key":"590_CR223","doi-asserted-by":"publisher","first-page":"9747","DOI":"10.1021\/acs.jcim.5c01478","volume":"65","author":"M Ljubi\u010d","year":"2025","unstructured":"Ljubi\u010d M, Sollner Dolenc M, Bori\u0161ek J, Perdih A. Water-based pharmacophore modeling in kinase inhibitor design: a case study on Fyn and Lyn protein kinases. J Chem Inf Model. 2025;65(18):9747\u201361.","journal-title":"J Chem Inf Model"},{"issue":"22","key":"590_CR224","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1021\/jm060434q","volume":"49","author":"LF Hennequin","year":"2006","unstructured":"Hennequin LF, Allen J, Breed J, Curwen J, Fennell M, Green TP, et al. N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src\/Abl kinase inhibitor. J Med Chem. 2006;49(22):6465\u201388.","journal-title":"J Med Chem"},{"issue":"19","key":"590_CR225","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1158\/1078-0432.CCR-10-0748","volume":"16","author":"J Baselga","year":"2010","unstructured":"Baselga J, Cervantes A, Martinelli E, Chirivella I, Hoekman K, Hurwitz HI, et al. Phase I safety, pharmacokinetics, and inhibition of SRC activity study of saracatinib in patients with solid tumors. Clin Cancer Res. 2010;16(19):4876\u201383.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"590_CR226","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224952","volume":"15","author":"H Yadikar","year":"2020","unstructured":"Yadikar H, Torres I, Aiello G, Kurup M, Yang Z, Lin F, et al. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization. PLoS ONE. 2020;15(7):e0224952.","journal-title":"PLoS ONE"},{"issue":"1","key":"590_CR227","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40478-020-00976-9","volume":"8","author":"SJ Tang","year":"2020","unstructured":"Tang SJ, Fesharaki-Zadeh A, Takahashi H, Nies SH, Smith LM, Luo A, et al. Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic tauopathy. Acta Neuropathol Commun. 2020;8(1):96.","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"590_CR228","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.1007\/s12035-024-04257-7","volume":"61","author":"S Meur","year":"2024","unstructured":"Meur S, Mukherjee S, Roy S, Karati D. Role of PIM kinase inhibitor in the treatment of Alzheimer\u2019s disease. Mol Neurobiol. 2024;61(12):10941\u201355.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"590_CR229","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimers Dement (N Y). 2023;9(2):e12385.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"19","key":"590_CR230","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.2174\/092986711796150531","volume":"18","author":"S Schenone","year":"2011","unstructured":"Schenone S, Brullo C, Musumeci F, Biava M, Falchi F, Botta M. Fyn kinase in brain diseases and cancer: the search for inhibitors. Curr Med Chem. 2011;18(19):2921\u201342.","journal-title":"Curr Med Chem"},{"issue":"10","key":"590_CR231","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1001\/jamaneurol.2019.2050","volume":"76","author":"CH van Dyck","year":"2019","unstructured":"van Dyck CH, Nygaard HB, Chen K, Donohue MC, Raman R, Rissman RA, et al. Effect of AZD0530 on cerebral metabolic decline in Alzheimer disease: a randomized clinical trial. JAMA Neurol. 2019;76(10):1219\u201329.","journal-title":"JAMA Neurol"},{"issue":"1","key":"590_CR232","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1021\/acsmedchemlett.5c00728","volume":"17","author":"H Shi","year":"2026","unstructured":"Shi H, Li Y, Liang SH. Selective 7-azaindole modulators targeting Fyn and GSK-3\u03b2 for dual-target neuromodulation. ACS Med Chem Lett. 2026;17(1):32\u20135.","journal-title":"ACS Med Chem Lett"},{"issue":"10","key":"590_CR233","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10100675","volume":"10","author":"HJ Choi","year":"2020","unstructured":"Choi HJ, Cha SJ, Lee JW, Kim HJ, Kim K. Recent advances on the role of GSK3\u03b2 in the pathogenesis of amyotrophic lateral sclerosis. Brain Sci. 2020;10(10):675.","journal-title":"Brain Sci"},{"issue":"17","key":"590_CR234","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1021\/acschemneuro.0c00363","volume":"11","author":"RMC Di Martino","year":"2020","unstructured":"Di Martino RMC, Pruccoli L, Bisi A, Gobbi S, Rampa A, Martinez A, et al. Novel curcumin-diethyl fumarate hybrid as a dualistic GSK-3\u03b2 inhibitor\/Nrf2 inducer for the treatment of Parkinson\u2019s disease. ACS Chem Neurosci. 2020;11(17):2728\u201340.","journal-title":"ACS Chem Neurosci"},{"issue":"33","key":"590_CR235","doi-asserted-by":"publisher","first-page":"9601","DOI":"10.1002\/anie.201603797","volume":"55","author":"SH Liang","year":"2016","unstructured":"Liang SH, Chen JM, Normandin MD, Chang JS, Chang GC, Taylor CK, et al. Discovery of a highly selective glycogen synthase kinase-3 inhibitor (PF-04802367) that modulates tau phosphorylation in the brain: translation for PET neuroimaging. Angew Chem Int Ed Engl. 2016;55(33):9601\u20135.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"590_CR236","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3233\/ADR-190135","volume":"3","author":"TK Das","year":"2019","unstructured":"Das TK, Jana P, Chakrabarti SK, Abdul Hamid MRW. Curcumin downregulates GSK3 and Cdk5 in scopolamine-induced Alzheimer\u2019s disease rats abrogating A\u03b2(40\/42) and tau hyperphosphorylation. J Alzheimers Dis Rep. 2019;3(1):257\u201367.","journal-title":"J Alzheimers Dis Rep"},{"key":"590_CR237","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114054","volume":"229","author":"S Demuro","year":"2022","unstructured":"Demuro S, Sauvey C, Tripathi SK, Di Martino RMC, Shi D, Ortega JA, et al. ARN25068, a versatile starting point towards triple GSK-3\u03b2\/FYN\/DYRK1A inhibitors to tackle tau-related neurological disorders. Eur J Med Chem. 2022;229:114054.","journal-title":"Eur J Med Chem"},{"issue":"7","key":"590_CR238","first-page":"4554","volume":"14","author":"D Davidson","year":"1994","unstructured":"Davidson D, Viallet J, Veillette A. Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cell-specific isoform of the Fyn tyrosine protein kinase. T cells Mol Cell Biol. 1994;14(7):4554\u201364.","journal-title":"T cells Mol Cell Biol"},{"issue":"1","key":"590_CR239","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13195-023-01169-x","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois B, L\u00f3pez-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, et al. Masitinib for mild-to-moderate Alzheimer\u2019s disease: results from a randomized, placebo-controlled, phase 3, clinical trial. Alzheimers Res Ther. 2023;15(1):39.","journal-title":"Alzheimers Res Ther"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-026-00590-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-026-00590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:02:35Z","timestamp":1790838155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40035-026-00590-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":239,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1186\/s40035-026-00590-0","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"52"}}